Merck Healthcare KGaA, Darmstadt, Germany Deal History & Licensing Activity
Merck Healthcare KGaA, Darmstadt, Germany is a large pharma. Over the past three years, Merck Healthcare KGaA, Darmstadt, Germany has been involved in 4 licensing and acquisition transactions, with a primary focus on mRNA (2 deals). The company currently has 17 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
4
Active Trials
17
Top Modality
mRNA
Focus Area
Solid Tumors
Merck Healthcare KGaA, Darmstadt, Germany Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Merck Healthcare KGaA, Darmstadt, Germany in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CML asset | Merck | mRNA | Unknown | license | Jun 9, 2026 |
| EYE103/MK-3000 | Merck | Other | Phase 3 | collaboration | Apr 7, 2026 |
| antibody discovery collaboration | Merck | Antibodies | Discovery | collaboration |
Merck Healthcare KGaA, Darmstadt, Germany Pipeline Focus
Therapeutic areas and modalities where Merck Healthcare KGaA, Darmstadt, Germany is most active based on deal history and clinical trial data.
Therapeutic Areas
Merck Healthcare KGaA, Darmstadt, Germany Clinical Pipeline
Merck Healthcare KGaA, Darmstadt, Germany has 17 active clinical trials across 4 development phases.
2
Unknown
8
Phase 1
4
Phase 2
3
Phase 3
See How Your Asset Matches Merck Healthcare KGaA, Darmstadt, Germany's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
mRNA Benchmarks
Upfront, milestone, and royalty benchmarks for mrna deals
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
About Merck Healthcare KGaA, Darmstadt, Germany Licensing & Deal Activity
Merck Healthcare KGaA, Darmstadt, Germany is a large pharma company that has been actively engaged in licensing transactions across the biopharma landscape. With 4 deals over the past three years, Merck Healthcare KGaA, Darmstadt, Germany ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Merck Healthcare KGaA, Darmstadt, Germany include Solid Tumors (6 deals and trials), Oncology (2 deals and trials), Ophthalmology (2 deals and trials), and Immunology (2 deals and trials). In terms of modality, Merck Healthcare KGaA, Darmstadt, Germany has shown particular interest in mrna, other, antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Merck Healthcare KGaA, Darmstadt, Germany and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Merck Healthcare KGaA, Darmstadt, Germany's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.